News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER launches new funding opportunity for pathobiology research
NIH invites investigators to apply for a new research opportunity, which funds pathobiology studies. Applicants can request use of data and biosamples from RECOVER observational studies and, for the first time, RECOVER clinical trials.
Announcement
53 Results
53 Results
RECOVER-TLC seeks input on planned study of possible Long COVID treatment
A public comment period will allow patients, caregivers, and researchers to comment on a study to test whether stellate ganglion nerve block (SGB) can help improve Long COVID symptoms.
Announcement
5 years in, RECOVER continues to advance its patient-centered mission
RECOVER marks 5 years of Long COVID research, with NIH leaders, scientists, and clinicians continuing to guide and advance the initiative’s mission. In 2026, RECOVER will expand clinical trials to find answers for the Long COVID community.
News Release
RECOVER-SLEEP enrollment process prioritized overall health of potential participants
While recruiting potential participants for its clinical trials focused on sleep disturbances, RECOVER study teams also conducted additional health screenings to identify and treat individuals with a sleep condition called sleep apnea.
Feature
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
RECOVER-TLC to hold next webinar January 23, 2026
On January 23, NIH and FNIH leaders will hold a RECOVER-TLC webinar to provide updates and answer questions about RECOVER’s latest clinical trial efforts.
Announcement
RECOVER-ENERGIZE clinical trials achieve early enrollment: How collaboration and communication drove success
A network of 42 RECOVER sites across the US worked to reach out to potential study participants, communicate with the trial team, and reach the trials’ enrollment goal 2 months ahead of schedule.
Feature
RECOVER-TLC invites public comments on upcoming clinical trials
Feedback from patients, caregivers, and others will help shape studies testing the safety and effectiveness of potential Long COVID treatments.
Announcement
RECOVER-NEURO clinical trial shares results of three non-drug treatments for cognitive symptoms of Long COVID
Results from the RECOVER-NEURO clinical trial were published in the journal JAMA Neurology. The trial focused on symptoms of cognitive dysfunction associated with Long COVID, including brain fog, trouble focusing, and thinking clearly.
News Release